Skip to main content

Table 2 Crude and adjusted odds ratios (ORs) for statin initiation by inflammatory rheumatic disease (IRD) sub-type

From: Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population

Condition Count Crude OR Adjusted OR
Rheumatoid arthritis 235 0.58 (0.45 to 0.75) 0.78 (0.58 to 1.05)
Polymyalgia rheumatica 59 0.38 (0.23 to 0.64) 0.73 (0.41 to 1.29)
Spondyloarthritis 84 0.41 (0.27 to 0.63) 0.43 (0.26 to 0.70)
Ankylosing spondylitis 19 0.72 (0.29 to 1.79) 0.54 (0.19 to 1.52)
Psoriatic arthropathies 64 0.36 (0.22 to 0.59) 0.42 (0.24 to 0.73)
Enteropathic arthropathies 1 - -
Systemic necrotising vascultis 37 0.32 (0.16 to 0.62) 0.44 (0.20 to 0.94)
Systemic lupus erythematosus 34 0.22 (0.10 to 0.46) 0.24 (0.11 to 0.59)
Systemic sclerosis 29 0.56 (0.27 to 1.16) 0.44 (0.20 to 1.01)
Sjogren’s syndrome 10 2.09 (0.44 to 9.84) 4.08 (0.64 to 26.04)
Dermatomyositis and polymyositis 5 0.78 (0.13 to 4.69) 0.86 (0.11 to 7.04)
Mixed Connective Tissue Disease 6 0.26 (0.05 to 1.43) 0.20 (0.03 to 1.52)
Total inflammatory rheumatic diseases 415 0.52 (0.43 to 0.63) 0.67 (0.54 to 0.84)
  1. Adjusted ORs were adjusted for age, gender, socio-economic status, geographic location and relevant co-morbidities. For sub-type, 80 patients had multiple (>1) IRD diagnoses but were counted only once in the primary analysis. Bolded text indicates statistically significant factors (P <0.05).